Alembic Pharma Slips as USFDA Issues Form 483
After the firm received Form 483, the shares of Alembic Pharmaceuticals declined 1.26 per cent to Rs 562.35 with four procedural observations for an inspection...
Download Unicorn Signals App
Powered By EquityPandit
